Miral, Nenita L.
HRN: 22-31-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
CEFUROXIME 500MG (TAB)
12/30/2025
01/06/2026
PO
1 Tab
Q12h
S/P NSVD
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes